0 0 0 0 2 0 more sensitive than clinical decline in sca1, sca3 and sca6. 0 2 5 7. brain. 2013 ; 136 : 905 – 17. 29. coarelli g, darios f, petit e, dorgham k, adanyeguh i, petit e, 44. adanyeguh im, perlbarg v, henry pg, rinaldi d, petit e, et al. plasma neurofilament light chain predicts cerebellar atrophy valabregue r, et al. autosomal dominant cerebellar ataxias : and clinical progression in spinocerebellar ataxia. neurobiol dis. imaging biomarkers with high effect sizes. neuroimage clin. 2021 ; 153 : 105311. https : / / doi. org / 1 0. 1 0 1 6 / j. n b d. 2 0 2 1. 1 0 5 3 1 1. 2018 ; 19 : 858 – 67. 30. wilke c, haas e, reetz k, faber j, garcia - moreno h, santana 45. piccinin cc, rezende tjr, de paiva jlr, moyses pc, martinez mm, et al. neurofilaments in spinocerebellar ataxia type 3 : blood arm, cendes f, franca mc. a 5 - year longitudinal clinical and biomarkers at the preataxic and ataxic stage in humans and mice. magnetic resonance imaging study in spinocerebellar ataxia type embo mol med. 2020 ; 12 : e11803. https : / / doi. org / 1 0. 1 5 2 5 2 / e m 3. mov disord. 2020 ; 35 : 1679 – 84. https : / / doi. org / 1 0. 1 0 0 2 / m d s. 2 m m. 2 0 1 9 1 1 8 0 3. 8 1 1 3. 31. peng y, zhang y, chen z, peng h, wan n, zhang j, et al. associ - 46. rezende tjr, petit e, park yw, du tezenas montcel s, joers jm, ation of serum neurofilament light and disease severity in patients dubois jm, et al. sensitivity of advanced magnetic resonance with spin